People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Curiteva, Inc. | — | Other Health Care | Series A | $12.0M | $23.3M | 2023 |
| Medseek Inc | — | Other Technology | Series A | $5.6M | $152.6M | 2009 |
Emerson Fann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Emerson Fann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Reaves | 1 | 4 |
| Mark Ludwig | 1 | 3 |
| Dennis Bottorff | 1 | 2 |
| Robert Leppo | 1 | 2 |
| Michael English | 1 | 2 |
| Don Johnson | 1 | 2 |
| Eric Linder | 1 | 1 |
| Philip Cupero | 1 | 1 |
| William Himmelsbach | 1 | 1 |
| Phil Cupero | 1 | 1 |
| Mike English | 1 | 1 |
| Daren McCormick | 1 | 1 |
| Robert Simmons | 1 | 1 |
| Peter Kuhn | 1 | 1 |
| Gale Wilson-Steele | 1 | 1 |
| Bill Voss | 1 | 1 |
| Chad Falciani | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.